156 related articles for article (PubMed ID: 17645850)
1. [Prognostic value of 9mTc-HL91 SPECT hypoxia imaging in patients with advanced NSCLC].
Li L; Yu JM; Sun XD; Zhu H; Yue JB; Sun CJ; Yang GR
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):127-30. PubMed ID: 17645850
[TBL] [Abstract][Full Text] [Related]
2. Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in nonsmall cell lung cancer.
Li L; Yu J; Xing L; Ma K; Zhu H; Guo H; Sun X; Li J; Yang G; Li W; Yue J; Li B
Am J Clin Oncol; 2006 Dec; 29(6):628-33. PubMed ID: 17149002
[TBL] [Abstract][Full Text] [Related]
3. [Correlations of 99 Tc m-HL91 SPECT hypoxia imaging with HIF-1alpha and VEGF expression in non-small cell lung cancer].
Li L; Hu M; Yu JM; Yang GR; Guo HB; Gao Y
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):669-73. PubMed ID: 20021862
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary study on the value of 99Tc(m)-HL91 imaging in predicting sensitivity to radiotherapy in patients with nasopharyngeal carcinoma].
Liu S; Xue Y; Zhang H; Liang JG; Lu XP; Liu XG; Chen SX; Jing NY
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):369-72. PubMed ID: 17892134
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of response to radiation therapy for human tumor xenografts using 99mTc-HL91 (4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime).
Suzuki T; Nakamura K; Kawase T; Kubo A
Ann Nucl Med; 2003 Apr; 17(2):131-8. PubMed ID: 12790362
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG.
Cook GJ; Houston S; Barrington SF; Fogelman I
J Nucl Med; 1998 Jan; 39(1):99-103. PubMed ID: 9443745
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic imaging with 99mTc-HL91 single photon emission computed tomography in advanced nonsmall cell lung cancer.
Li L; Yu JM; Xing LG; Yang GR; Sun XD; Xu J; Zhu H; Yue JB
Chin Med J (Engl); 2006 Sep; 119(17):1477-80. PubMed ID: 16989751
[No Abstract] [Full Text] [Related]
8. [Clinical application of 99mTc-HL91 hypoxia imaging in nasopharyngeal carcinoma].
Zheng YJ; Fan W; Zhao C; Yang XC; Cui NJ; Chen FJ
Ai Zheng; 2006 Mar; 25(3):378-81. PubMed ID: 16536999
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-HL91 "hot spot" imaging of mice bearing human carcinoma by gamma camera and the effects of tumor necrosis on imaging.
Yao Z; Qu W; Zhou Y; Zhu M; Zhu L
Chin Med J (Engl); 2000 May; 113(5):404-7. PubMed ID: 11776093
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.
Eschmann SM; Paulsen F; Reimold M; Dittmann H; Welz S; Reischl G; Machulla HJ; Bares R
J Nucl Med; 2005 Feb; 46(2):253-60. PubMed ID: 15695784
[TBL] [Abstract][Full Text] [Related]
11. [Biodistribution of hypoxic marker, 99mTc-HL91 (4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime)].
Suzuki T; Nakamura K; Kawase T; Kubo A
Kaku Igaku; 2001 Jul; 38(4):333-41. PubMed ID: 11530380
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis of locally advanced non small cell lung cancer treated with three dimentional conformal radiotherapy].
Zhu XZ; Wang LH; Ou GF; Zhou ZM; Chen DF; Xiao ZF; Feng QF; Zhang HX; Wang M; Yin WB
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):748-53. PubMed ID: 18396686
[TBL] [Abstract][Full Text] [Related]
13. (99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer.
Chen B; Zhao G; Ma Q; Ji B; Ji T; Xin H; Gao S
Int J Clin Exp Pathol; 2015; 8(12):16064-72. PubMed ID: 26884883
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of Tc-99m HL91 in tumor hypoxia: in vitro cell culture and in vivo tumor model.
Lee BF; Chiu NT; Hsia CC; Shen LH
Kaohsiung J Med Sci; 2008 Sep; 24(9):461-72. PubMed ID: 19073378
[TBL] [Abstract][Full Text] [Related]
15. (99m)Tc-3PRGD 2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab.
Ma Q; Min K; Wang T; Chen B; Wen Q; Wang F; Ji T; Gao S
Ann Nucl Med; 2015 Jul; 29(6):519-27. PubMed ID: 25911312
[TBL] [Abstract][Full Text] [Related]
16. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.
Honess DJ; Hill SA; Collingridge DR; Edwards B; Brauers G; Powell NA; Chaplin DJ
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):731-5. PubMed ID: 9845086
[TBL] [Abstract][Full Text] [Related]
18. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia imaging of patients with acute myocardial infarction by using dual isotopes of 201Tl and 99mTc-HL91.
Yang XJ; He YM; Wu YW; Zhang B; Hui J; Jiang TB; Song JP; Liu ZH; Jiang WP
Nucl Med Commun; 2008 Mar; 29(3):230-8. PubMed ID: 18349793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
